The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,670.00
Bid: 1,670.50
Ask: 1,671.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.03%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,670.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK blocks Shell paying Iran oil debt in food, medicine

Mon, 22nd Apr 2013 12:44

By Richard Mably

LONDON, April 22 (Reuters) - Britain has blocked efforts byoil major Royal Dutch Shell to settle a $2.3 billiondebt it owes Iran by paying in kind with grains orpharmaceuticals, industry sources said.

Shell has been trying for months to find a way to workaround international sanctions that prevent it paying incurrency for crude it bought from the National Iranian OilCompany before a European Union embargo on Iran that startedlast July.

The sources said the British government was reluctant toprovide relief for the Iranian economy when Western powers areusing sanctions to apply financial pressure on Tehran todismantle its nuclear programme.

"The view is that doesn't make sense to smooth the way for apayment that helps Iran when government is trying to press Iranto negotiate," said an industry source.

A government spokesman declined comment on the Shell casebut said: "The government fully backs the tough regime of EUsanctions that have been put in place against Iran."

Talks earlier this month between Iran and six world powersincluding Britain failed to make progress in resolving adecade-old dispute around Iran's nuclear progress. Another roundof negotiations has been scheduled for May 21.

The industry sources said Shell in February explored withthe British government the possibility of asking Britishpharmaceuticals maker GSK to deliver medicines to Iranin a payment-in-kind deal known as an offset agreement.

GSK said it had not been approached or held any discussionson the matter. Shell declined comment.

In October, the Anglo-Dutch oil company sought permissionfor an offset agreement that would have seen U.S. agriculturaltrader Cargill deliver grain to Iran.

Following publication by Reuters, Dutch foreign ministerFrans Timmermans in a letter to parliament acknowledged theproposal, saying: "As in all sanctions regimes there are somecarefully defined exceptions applicable for which in certaincases an exemption can be granted by national governments."

Meetings were held with Cargill but, said the industrysources, the proposal was turned down by the British government.Cargill and Shell both declined comment at the time.

MAINTAINING IRAN RELATIONSHIP

The sources said the oil company wanted to repay its debt toNIOC to maintain cordial relations with Iran, one of the biggestproducers in the Organization of the Petroleum ExportingCountries.

"Politics come and go but it's in the interests of Shell andits shareholders to pay its debts and maintain a relationshipwith a leading oil producer like Iran," said one of the sources.

Shell revealed in a March filing to U.S. regulatoryauthorities that it owed Tehran $2.3 billion and made a net lossof $6 million trading Iranian oil in 2012. Unlike its rivals,Shell continued trading with Iran under a provision forpre-existing contracts close to the EU's June 30 deadline beforethe embargo. The debt is for oil purchased in 2011 and 2012.

Iran's oil revenues have fallen by about 50 percent sincesanctions were imposed last year, and regional economistsbelieve it has been forced to draw on its foreign reserves tohelp buy essentials like grains.

But with an estimated $100 billion of foreign reserves atthe start of 2012, thanks to high oil prices, the Iranianeconomy is far from collapse.

The International Monetary Fund said last week that whilesanctions had frozen Iran out of the international bankingsystem, Tehran was avoiding a balance-of-payments crisis andshould emerge from recession in 2014.

Food and medicine are among the humanitarian goods notbarred by U.S. and European sanctions but, isolated frominternational banking, Iran has been forced to pay a premium forgrain imports.

Washington has tried to restrict countries like China,India, South Korea and Japan that still buy Iranian oil topaying for shipments by the barter of approved goods - includingfood and medicine.

U.S. sanctions state that funds used to pay for oil mustremain in a bank account in the purchasing country and can beused only for non-sanctioned, bilateral trade between thatcountry and Iran. Any bank that repatriates the money ortransfers it to a third country faces a U.S. sanction risk.

Nevertheless, said the industry sources, it appears theBritish government would rather Iran be obliged to spend foreignreserves or use oil revenues to barter for essential importsthan benefit from shipments of humanitarian goods paid for byShell debt.

More News
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.